CN116391864A - Method for assembling nano-embedded lutein by pH (potential of hydrogen) synergistic ethanol-induced protein, protein-based lutein nanoparticle and application - Google Patents
Method for assembling nano-embedded lutein by pH (potential of hydrogen) synergistic ethanol-induced protein, protein-based lutein nanoparticle and application Download PDFInfo
- Publication number
- CN116391864A CN116391864A CN202310243522.3A CN202310243522A CN116391864A CN 116391864 A CN116391864 A CN 116391864A CN 202310243522 A CN202310243522 A CN 202310243522A CN 116391864 A CN116391864 A CN 116391864A
- Authority
- CN
- China
- Prior art keywords
- protein
- lutein
- ethanol
- nano
- alkaline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title claims abstract description 390
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 294
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 294
- 229960005375 lutein Drugs 0.000 title claims abstract description 230
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 title claims abstract description 230
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 title claims abstract description 230
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 title claims abstract description 230
- 239000001656 lutein Substances 0.000 title claims abstract description 229
- 235000012680 lutein Nutrition 0.000 title claims abstract description 229
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 title claims abstract description 229
- 239000002105 nanoparticle Substances 0.000 title claims abstract description 113
- 238000000034 method Methods 0.000 title claims abstract description 82
- 230000002195 synergetic effect Effects 0.000 title claims abstract description 10
- 239000001257 hydrogen Substances 0.000 title description 3
- 229910052739 hydrogen Inorganic materials 0.000 title description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 title description 2
- 235000019441 ethanol Nutrition 0.000 claims abstract description 133
- 239000000243 solution Substances 0.000 claims abstract description 87
- 230000002209 hydrophobic effect Effects 0.000 claims abstract description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 26
- 239000006185 dispersion Substances 0.000 claims abstract description 17
- 235000013305 food Nutrition 0.000 claims abstract description 14
- 238000002360 preparation method Methods 0.000 claims abstract description 13
- 238000003756 stirring Methods 0.000 claims abstract description 10
- 238000001704 evaporation Methods 0.000 claims abstract description 9
- 239000003814 drug Substances 0.000 claims abstract description 7
- 230000007935 neutral effect Effects 0.000 claims abstract description 5
- 239000000049 pigment Substances 0.000 claims abstract description 5
- 230000008707 rearrangement Effects 0.000 claims abstract description 3
- 235000018102 proteins Nutrition 0.000 claims description 282
- 239000002245 particle Substances 0.000 claims description 95
- 239000011259 mixed solution Substances 0.000 claims description 21
- 230000003993 interaction Effects 0.000 claims description 19
- 238000010438 heat treatment Methods 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 13
- 102000011632 Caseins Human genes 0.000 claims description 11
- 108010076119 Caseins Proteins 0.000 claims description 11
- 108010046377 Whey Proteins Proteins 0.000 claims description 10
- 238000002390 rotary evaporation Methods 0.000 claims description 10
- 229940080237 sodium caseinate Drugs 0.000 claims description 10
- 235000021119 whey protein Nutrition 0.000 claims description 10
- 102000007544 Whey Proteins Human genes 0.000 claims description 9
- 238000010494 dissociation reaction Methods 0.000 claims description 9
- 230000005593 dissociations Effects 0.000 claims description 9
- 230000008020 evaporation Effects 0.000 claims description 8
- 229940071440 soy protein isolate Drugs 0.000 claims description 8
- 230000001105 regulatory effect Effects 0.000 claims description 7
- 235000021374 legumes Nutrition 0.000 claims description 4
- 238000005215 recombination Methods 0.000 claims description 4
- 230000006798 recombination Effects 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 3
- 229940079593 drug Drugs 0.000 claims description 3
- 101710102211 11S globulin Proteins 0.000 claims description 2
- 102000004506 Blood Proteins Human genes 0.000 claims description 2
- 108010017384 Blood Proteins Proteins 0.000 claims description 2
- 101000767750 Carya illinoinensis Vicilin Car i 2.0101 Proteins 0.000 claims description 2
- 101000767759 Corylus avellana Vicilin Cor a 11.0101 Proteins 0.000 claims description 2
- 101710190853 Cruciferin Proteins 0.000 claims description 2
- 101000622316 Juglans regia Vicilin Jug r 2.0101 Proteins 0.000 claims description 2
- 108010060630 Lactoglobulins Proteins 0.000 claims description 2
- 102000008192 Lactoglobulins Human genes 0.000 claims description 2
- 102000016943 Muramidase Human genes 0.000 claims description 2
- 108010014251 Muramidase Proteins 0.000 claims description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims description 2
- 108010058846 Ovalbumin Proteins 0.000 claims description 2
- 108010084695 Pea Proteins Proteins 0.000 claims description 2
- 101000767757 Pinus koraiensis Vicilin Pin k 2.0101 Proteins 0.000 claims description 2
- 101000767758 Pistacia vera Vicilin Pis v 3.0101 Proteins 0.000 claims description 2
- 230000002708 enhancing effect Effects 0.000 claims description 2
- 239000004325 lysozyme Substances 0.000 claims description 2
- 235000010335 lysozyme Nutrition 0.000 claims description 2
- 229960000274 lysozyme Drugs 0.000 claims description 2
- 229940092253 ovalbumin Drugs 0.000 claims description 2
- 235000019702 pea protein Nutrition 0.000 claims description 2
- 238000005538 encapsulation Methods 0.000 abstract description 18
- 230000029087 digestion Effects 0.000 abstract description 13
- 230000008569 process Effects 0.000 abstract description 12
- 238000003860 storage Methods 0.000 abstract description 6
- 239000002994 raw material Substances 0.000 abstract description 2
- 108020005087 unfolded proteins Proteins 0.000 abstract description 2
- 239000012460 protein solution Substances 0.000 abstract 1
- 230000014759 maintenance of location Effects 0.000 description 21
- 230000001965 increasing effect Effects 0.000 description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 125000001165 hydrophobic group Chemical group 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- 238000009826 distribution Methods 0.000 description 10
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 9
- 238000003760 magnetic stirring Methods 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 8
- 230000002776 aggregation Effects 0.000 description 7
- 238000004220 aggregation Methods 0.000 description 7
- 108010073771 Soybean Proteins Proteins 0.000 description 6
- 230000006698 induction Effects 0.000 description 6
- 230000009471 action Effects 0.000 description 5
- 235000012754 curcumin Nutrition 0.000 description 5
- 239000004148 curcumin Substances 0.000 description 5
- 229940109262 curcumin Drugs 0.000 description 5
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 229940001941 soy protein Drugs 0.000 description 5
- 238000010586 diagram Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000003094 microcapsule Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 238000005265 energy consumption Methods 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000006432 protein unfolding Effects 0.000 description 3
- 229920001287 Chondroitin sulfate Polymers 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 235000013734 beta-carotene Nutrition 0.000 description 2
- 239000011648 beta-carotene Substances 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 235000021466 carotenoid Nutrition 0.000 description 2
- 150000001747 carotenoids Chemical class 0.000 description 2
- 229940059329 chondroitin sulfate Drugs 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000000411 inducer Substances 0.000 description 2
- 238000012994 industrial processing Methods 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 238000001338 self-assembly Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000009210 therapy by ultrasound Methods 0.000 description 2
- 238000009777 vacuum freeze-drying Methods 0.000 description 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 2
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 108700037728 Glycine max beta-conglycinin Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 238000006683 Mannich reaction Methods 0.000 description 1
- 108010053210 Phycocyanin Proteins 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 206010064930 age-related macular degeneration Diseases 0.000 description 1
- 230000004931 aggregating effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000002902 bimodal effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000019705 chickpea protein Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000020510 functional beverage Nutrition 0.000 description 1
- 102000034356 gene-regulatory proteins Human genes 0.000 description 1
- 108091006104 gene-regulatory proteins Proteins 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000000416 hydrocolloid Substances 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 208000002780 macular degeneration Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002539 nanocarrier Substances 0.000 description 1
- 239000007908 nanoemulsion Substances 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 239000003495 polar organic solvent Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000004845 protein aggregation Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 235000008210 xanthophylls Nutrition 0.000 description 1
- 150000003749 zeaxanthins Chemical class 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/105—Aliphatic or alicyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/03—Organic compounds
- A23L29/035—Organic compounds containing oxygen as heteroatom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/03—Organic compounds
- A23L29/045—Organic compounds containing nitrogen as heteroatom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/40—Colouring or decolouring of foods
- A23L5/42—Addition of dyes or pigments, e.g. in combination with optical brighteners
- A23L5/43—Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives
- A23L5/44—Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives using carotenoids or xanthophylls
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5169—Proteins, e.g. albumin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Nanotechnology (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Optics & Photonics (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
Abstract
The invention discloses a method for assembling nano-embedded lutein by utilizing pH synergistic ethanol-induced protein, protein-based lutein nano-particles and application thereof. The preparation method comprises the following steps: adjusting the pH of the protein dispersion to be alkaline, fully stirring, and dripping the lutein-absolute ethyl alcohol solution into the alkaline protein solution; during the process of evaporating and removing ethanol, the unfolded alkaline protein is folded to ensure that lutein is encapsulated in a protein hydrophobic cavity; and (3) in the process of adjusting the pH to be neutral, the unfolded protein is subjected to secondary folding and rearrangement, and lutein is subjected to secondary encapsulation, so that the protein-based lutein nanoparticle with compact structure is finally formed. The method has the advantages of simple equipment, simple and convenient steps, safety, greenness, easily available raw materials, economy and high efficiency; the prepared protein-based lutein nano-particles remarkably improve the water dispersibility, the heat stability, the light stability, the storage stability, the digestion stability and the bioavailability of lutein; therefore, the method has wide development prospect in industries such as pigment, feed, food, medicine and the like.
Description
Technical Field
The invention belongs to the technical field of food bioactive substance nano-embedding, and particularly relates to a method for assembling nano-embedded lutein by utilizing pH to cooperate with ethanol to induce protein, protein-based lutein nano-particles and application.
Background
Lutein and zeaxanthin isomer thereof are oxygen-containing carotenoids other than provitamin A, contain very polyunsaturated double bonds in the structure, and have excellent oxidation resistance. They can act to prevent age-related maculopathy and cataract by antioxidant effect and blue-wave filtering effect. As with most hydrophobic bioactive substances, lutein is poorly soluble in water, can be dissolved in organic solvents such as ethanol, ethyl acetate, dichloromethane and the like, is extremely sensitive to light and heat, and has low bioavailability, thus severely limiting the application thereof in the food field.
In order to solve the problems, the lutein is usually encapsulated by microcapsule, nanoparticle, emulsion and other systems at home and abroad, and ethanol is usually used as a solvent to introduce the lutein. Zhao et al (Physicochemical Properties of Lutein-Loaded Microcapsules and Their Uptake via Caco-2 Monolayers [ J ]. Molecular, 2018,23 (7): 1805) drop lutein-ethanol solution into sodium caseinate-ethanol solution after heat treatment at 60deg.C for 5min, high-speed dispersion at 10000rpm for 4min, sieving with 100 mesh sieve to remove insoluble large particles, and spray drying to obtain microcapsule with encapsulation rate of 89.95%, wherein lutein retention rate is 79.83% after dark treatment at 25deg.C for 5d, and microcapsule particles are generally larger and biological potency is not high. Dai et al (Stable Nanoparticles Prepared by Heating Electrostatic Complexes of Whey Protein Isolate-Dextran Conjugate and Chondroitin Sulfate [ J ]. Journal of Agricultural and Food Chemistry,2015,63 (16): 4179-4189) added lutein-ethanol solution into whey protein isolate-dextran-chondroitin sulfate ternary nanoparticle solution, cavitation of ultrasonic wave was utilized to promote migration of lutein molecules into nanoparticle, encapsulation rate could reach 94.07%, average particle size of nanoparticle loaded with lutein was 150nm, but preparation process involved heating, ice bath, ultrasonic treatment, steps were complicated and equipment was expensive.
The patent CN 113143885A is prepared by dissolving lutein in 95% ethanol solution and preparing lutein particles with the particle size of 100-1000nm by using a supercritical emulsification technology, wherein the average particle size can be below 400nm under the preferred condition, but the supercritical emulsification technology cannot realize large-scale industrial application at present. The patent CN 114468295A is characterized in that an phycocyanin solution synthesized based on Mannich reaction and a lutein ethanol solution are mixed and stirred for 24 hours in equal volume, ethanol is evaporated to obtain nano particles loaded with lutein, the size is 370+/-50 nm, the embedding rate is only 74.42%, and the particles are large and have low embedding rate. The patent CN 111938157A adds lutein-absolute ethyl alcohol solution into chickpea protein isolate-stevioside composite system, uses a probe type ultrasonic breaker to carry out ultrasonic treatment for 6-10min and volatilizes the ethyl alcohol to obtain lutein nano emulsion with the average particle size of 195.1nm, and also has the problem of expensive equipment.
The problem of large particle size, low embedding efficiency and low retention rate exists in the particles prepared by the lutein embedding technology with ethanol as a solvent. This is because ethanol as a polar organic solvent can change the natural conformation of the protein molecule, so that the protein is unfolded to expose a large number of hydrophobic groups, and hydrophobic active substances dissolved in ethanol can be combined with the protein to form a complex through hydrophobic interaction; at the same time, however, ethanol also has the effect of promoting aggregation of proteins, which on the one hand results in a particle size which is far greater than that of the native protein and on the other hand in a decrease in the entrapment efficiency of the hydrophobic active substance with increasing ethanol concentration, which mechanism is revealed by Liu et al (Novel so beta-conglycinin nanoparticles by ethanol-assisted disassembly and reassembly: outstanding nanocarriers for hydrophobic nutraceuticals [ J ]. Food Hydrocolloids,2019, 91:246-255.). The common solution is to crush, squeeze and shear the particles by ultrasonic, high pressure and micro-jet to reduce the size of the particles, promote the migration of lutein molecules into the particles to improve the encapsulation efficiency, but all the defects of expensive equipment and high cost are accompanied.
Therefore, the related lutein embedding technology patent with simple equipment, convenient and fast method, high embedding efficiency and smaller size is not published at present.
The patent CN 113080452A encapsulates the curcumin in the protein by utilizing the characteristics of increased water solubility of curcumin phenolic hydroxyl ionization and protein unfolding and even dissociation into subunits under the alkaline pH condition, realizes high-efficiency loading of the curcumin, and improves the water solubility, stability and bioavailability of the curcumin. Pan et al (pH-driven encapsulation of curcumin in self-assembled casein nanoparticles for enhanced dispersibility and bioactivity [ J ]. Soft Matter,2014,10 (35): 6820-6830.) found that recombinant particle size formed after pH adjustment of treated sodium caseinate to pH 7 at pH=12 was significantly smaller than the protein particle size without alkali treatment. Therefore, the pH induced protein self-assembly not only can realize efficient embedding of the hydrophobic active substance, but also can prepare the recombinant particles with smaller size, and the preparation process is simple, safe, low in cost and low in energy consumption.
In summary, the invention provides a method for assembling nano-embedded lutein by pH cooperated with ethanol induced protein, which is based on the following principle: under the alkaline pH condition, the protein is far away from the isoelectric point, the electrostatic repulsive force among alkaline protein molecules is increased along with the increase of the pH value, so that the protein is unfolded or even dissociated Cheng Yaji, hydrophobic groups in the protein molecules are exposed to a hydrophilic environment, at the moment, self-assembled units are obviously reduced, and the protein dispersion liquid becomes clear and transparent; ethanol is used as an inducer to promote the alkaline dissociated proteins to be further unfolded, the exposure degree of hydrophobic groups is increased, the hydrophobic effect among the alkaline dissociated proteins is also enhanced, loose and larger aggregates are formed, and meanwhile, the ethanol is used as a solvent to introduce lutein, so that the lutein can be combined with the hydrophobic groups fully exposed by the alkaline dissociated proteins through hydrophobic interaction to form a compound, and the solution becomes turbid; in the process of removing the ethanol, fully developed alkaline dissociated proteins start to fold back, lutein is encapsulated in subunits for the first time or is combined with the surfaces of protein molecules, loose structures become converged, originally aggregated alkaline dissociated protein particles return to a state of being separated from each other when the ethanol is not added, the size of the particles is obviously reduced, and the solution becomes clear again; and (3) in the process of adjusting the pH to be neutral, the unfolded or dissociated protein is continuously folded and recombined, lutein is subjected to secondary encapsulation, the loose structure becomes compact, and finally the protein-based lutein nano-particle similar to the natural protein structure is formed.
The method has the advantages of simple equipment, simple and convenient process and low cost, and the prepared protein-based lutein nano-particles can realize high-efficiency encapsulation of lutein and can also improve the water solubility, stability and bioavailability of lutein. Is suitable for large-scale industrial production and processing, and has certain application prospect in the fields of pigment, feed, food, medicine and the like.
Disclosure of Invention
In view of the drawbacks and deficiencies of the prior art, a first aspect of the present invention is directed to a method for assembling nano-embedded lutein by pH-synergistic ethanol-induced protein. The method utilizes protein to fold or dissociate into subunits under alkaline pH condition to expose a large amount of hydrophobic groups in the protein to the surface of the protein; then introducing lutein-absolute ethanol solution, wherein ethanol is used as an inducer to promote the protein to be unfolded and aggregated, and is used as a solvent to introduce lutein to form a complex with the protein through hydrophobic interaction; removing ethanol by evaporation to enable the unfolded alkaline dissociated protein to be folded for the first time, enabling lutein to be subjected to first embedding, and weakening the characteristic that ethanol is utilized to promote protein particles to gather by electrostatic repulsive force, so that the particle size is obviously reduced; and finally, the pH value is adjusted back to enable the unfolded or dissociated protein to carry out secondary folding and recombination, and lutein is subjected to secondary embedding at the same time, so that the protein-based lutein nanoparticle similar to the natural protein structure is formed.
The purpose of the second aspect of the invention is to prepare the protein-based lutein nanoparticle which is easy to disperse, high in water solubility, high in embedding rate, high in stability and high in bioavailability by the method.
The third aspect of the present invention is aimed at realizing commercial application of the above protein-based lutein nanoparticle.
In order to achieve the above purpose, the technical scheme adopted by the invention is as follows:
(1) The pH of the protein dispersion is adjusted to be in an alkaline state, and the protein is fully stirred to be unfolded or dissociated into subunits, so that the particle size is obviously reduced, and the solution becomes clear and transparent; then adding a certain volume ratio of lutein-absolute ethyl alcohol solution, enabling the alkaline dissociated protein to be further unfolded through alcohol-water interaction by the aid of the ethyl alcohol, fully stirring to enable the lutein to form a stable compound with the protein through hydrophobic interaction, and meanwhile, enhancing the hydrophobic interaction among alkaline dissociated protein particles to form a loose aggregate with larger size, so that the solution becomes turbid.
(2) The ethanol in the mixed solution is removed by rotary evaporation, the unfolded alkaline dissociation proteins are gradually overlapped, the loose structure starts to be converged, lutein is subjected to first embedding, the aggregated alkaline protein particles return to a state of being separated from each other when no ethanol is added, the particle size is obviously reduced, and the solution becomes clear again.
(3) Regulating pH of the mixed solution to be neutral, carrying out rearrangement of subunits separated from each other originally by electrostatic repulsive force, carrying out secondary overlapping and recombination on protein, carrying out secondary embedding on lutein, enabling a loose structure to become compact, and adding water with the same volume as ethanol removed by evaporation to obtain the protein-based lutein nano-particles.
Further, the protein in the step (1) is at least one of whey protein, serum protein, ovalbumin, lysozyme, beta-lactoglobulin, sodium caseinate, legume 7S globulin, legume 11S globulin, soy protein isolate and pea protein isolate; preferably, the protein is at least one of soy protein isolate, sodium caseinate and whey protein isolate.
Further, the protein concentration in the step (1) is 1-60mg/mL; preferably, the protein concentration is 5-30mg/mL; more preferably, the protein concentration is 5-20mg/mL.
Further, the pH range of the protein dispersion liquid in the step (1) is adjusted to be 10-12, and the stirring time is 30-120min; preferably, the pH of the regulatory protein dispersion is in the range of 11-12 and the stirring time is 60-120min.
Further, the concentration of the lutein-absolute ethanol solution in the step (1) is 0.5-1.5mg/mL.
Further, the lutein-absolute ethyl alcohol solution is added in the step (1) in a volume ratio of 10-70% of the mixed solution, and the stirring time is 30-120min; preferably, the volume ratio of the lutein-absolute ethyl alcohol solution is 40% -60% of the mixed solution, the stirring time is 60-120min, more preferably, the volume ratio of the lutein-absolute ethyl alcohol solution is 40% -50% of the mixed solution, and the stirring time is 60-120min.
Further, the rotary evaporation vacuum degree in the step (2) is 0-0.1MPa, the heating temperature is 35-45 ℃, and the rotating speed is 80-120rpm.
Further, the pH value of the step (3) is adjusted to 6.8-8.0; preferably, step (3) adjusts the pH to 6.8-7.2.
The invention provides protein-based lutein nanoparticle prepared by the method for assembling nano-embedded lutein by utilizing the pH synergistic ethanol-induced protein.
The invention provides an application of protein-based lutein nano particles prepared by a method for assembling nano-embedded lutein by utilizing pH synergistic ethanol-induced protein in preparation of products, and further, the products are any one of (1) - (4): (1) The pigment can be used as a colorant for producing foods such as cakes and candies to give orange-yellow appearance; (2) Food can be directly used as dietary supplement or used as auxiliary material to produce lutein-reinforced food such as functional beverage, etc.; (3) The medicine can be used as an auxiliary material to produce medicines for relieving eye fatigue; (4) The feed can be used as chicken feed to enrich xanthophyll in egg.
The principle of the invention is as follows: lutein is a type of oxygen-containing carotenoid which is not provitamin A, is insoluble in water, but is soluble in ethanol, and has multiple hydrophobic sites in lutein molecules, and can be combined with protein through hydrophobic interaction. The hydrophobic sites of the native protein are located inside the molecule, while the structure of the protein is maintained by hydrogen bonding, hydrophobic interactions, and electrostatic forces. It has been found that both ethanol and pH can alter the natural structure of proteins, allowing proteins to unfold or dissociate, especially in alkaline pH conditions, certain proteins dissociate Cheng Yaji, thus exposing much of the originally buried hydrophobic groups to the surface of the protein molecule; in the presence of ethanol, the alkaline dissociated proteins on the one hand further unfold exposing more hydrophobic sites causing aggregation of the particles and on the other hand forming complexes with lutein by hydrophobic interactions; in the process of removing ethanol, the alkaline dissociating proteins with loose structures are subjected to first folding, part of lutein is embedded in the alkaline dissociating proteins, and the aggregated alkaline dissociating protein particles return to a state of being separated from each other when no ethanol is added; in the process of adjusting the pH to be neutral, the unfolded or dissociated protein molecules are subjected to secondary folding and recombination, lutein on the surface of the protein can be further embedded, and finally, new particles similar to the structure of the natural protein are formed.
In conclusion, the protein-based lutein nanoparticle prepared by assembling nano-embedded lutein through pH and ethanol-induced protein can realize efficient embedding of lutein, solve the defects of poor water dispersibility, poor stability and low bioavailability of lutein, and improve the stability of lutein products in the food processing process and finally the effective absorption of the lutein products in human bodies.
The preparation method has the advantages of simple and safe preparation process, low cost and low energy consumption, can realize efficient encapsulation, and can be applied to various occasions.
Compared with the prior art, the invention has the following beneficial effects:
(1) The invention provides a method for assembling nano-embedded lutein by utilizing pH synergistic ethanol induced protein for the first time, which has the advantages of simple equipment, simple and convenient steps, safety, greenness, low cost and low energy consumption, is suitable for large-scale industrial production and processing, meets the food safety requirements in the production process and materials, is suitable for pigment, food, medicine and feed industries, and has wide application prospect.
(2) According to the method for assembling nano-embedded lutein by utilizing the pH and alcohol to induce the protein, the characteristics of the natural structure of the protein can be changed by utilizing the alcohol and the pH, so that the protein is unfolded, dissociated and recombined twice, the lutein is efficiently encapsulated, the characteristic of promoting protein aggregation by utilizing electrostatic repulsive force to weaken the alcohol, and finally the protein-based lutein nano-particle with compact structure and smaller size is formed.
(3) According to the method for assembling nano-embedded lutein by utilizing the pH synergistic alcohol to induce the protein, the size of the formed protein-based lutein nano-particles can be regulated and controlled by changing the pH, the protein concentration, the alcohol concentration and the time of pH synergistic alcohol induction.
(4) The protein-based lutein nanoparticle prepared by adopting pH to cooperate with ethanol to induce protein to assemble nano-embedded lutein can improve the water dispersibility, the thermal stability, the light stability, the storage stability and the bioavailability of lutein.
Drawings
FIG. 1 is a solution appearance diagram of the protein-based lutein nanoparticle prepared in examples 1-4;
FIG. 2 is a graph showing particle size distribution of protein-based lutein nanoparticles prepared from different proteins in example 1;
FIG. 3 is a powder appearance diagram of the protein-based lutein nanoparticle in the form of solution prepared from different proteins in example 1 after vacuum freeze drying;
FIG. 4 is a graph showing particle size distribution of protein-based lutein nanoparticles prepared under different pH conditions in example 2;
FIG. 5 is a graph showing particle size distribution of protein-based lutein nanoparticles prepared under different protein concentration conditions in example 3;
FIG. 6 is a graph showing lutein retention rate after heat treatment of lutein-absolute ethanol solution and protein-based lutein nanoparticles prepared under different protein concentration conditions in example 3 at 80 ℃;
FIG. 7 is a graph showing the lutein retention rate of the lutein-based nanoparticle prepared under the condition of different protein concentrations in example 3 after the lutein-absolute ethanol solution is irradiated with ultraviolet light;
FIG. 8 is a graph showing particle size distribution of protein-based lutein nanoparticles prepared under different ethanol concentration conditions in example 4 and comparative example 1;
FIG. 9 is a transmission scanning electron microscope image of the protein-based lutein nanoparticle prepared in example 4 and comparative example 1 at 40% ethanol concentration;
FIG. 10 is a graph showing the lutein retention rate after storage of the protein-based lutein nanoparticles and lutein-anhydrous ethanol solution in the form of solution prepared under different ethanol concentration conditions at 35℃in the example 4 in the absence of light;
FIG. 11 is a graph showing the retention of lutein after simulated gastric digestion and/or intestinal digestion of protein-based lutein nanoparticles and lutein-absolute ethanol solution in the form of solutions prepared under different ethanol concentration conditions in example 4;
FIG. 12 is a statistical plot of lutein retention and bioavailability of lutein in the form of solutions prepared under different ethanol concentration conditions in example 4 after simulated gastric digestion and/or intestinal digestion of lutein-anhydrous ethanol solution.
Detailed Description
The invention is further illustrated by the following specific examples of implementation.
It is to be understood that these examples are illustrative of the present invention and are not intended to limit the scope of the present invention.
The experimental methods in each of the following examples, in which specific conditions are not noted, are generally performed under conventional conditions or under conditions recommended by the manufacturer. The materials, reagents and the like used in this example are commercially available ones unless otherwise specified.
Example 1
Method 1: the protein-based lutein nanoparticle prepared by a method for assembling nano-embedded lutein by utilizing pH and ethanol to induce protein comprises the following steps:
(1) Whey protein isolate was dispersed in water to an initial concentration of 16.7mg/mL, the pH of the dispersion was adjusted to 12.0 with 4M NaOH solution, and magnetic stirring was continued at 1000rpm/min for 120min at room temperature to allow the protein to be fully unfolded or dissociated and the solution became clear and transparent. 1.5mg/mL lutein-absolute ethanol solution is dripped into the alkaline dissociating protein dispersion liquid to ensure that the absolute ethanol concentration reaches 40% (v/v) of the mixed liquid, the pH value is maintained at 12.0 during the period, the final concentration of the alkaline dissociating protein is 10mg/mL, and the magnetic stirring is continued at the speed of 1000rpm/min for 30min at room temperature. Under the action of ethanol, the alkaline dissociative protein is further unfolded to fully expose hydrophobic groups, on one hand, the alkaline dissociative protein forms a complex with lutein through hydrophobic interaction, on the other hand, the alkaline dissociative protein is aggregated into loose large particles, and the solution becomes turbid.
(2) Removing the ethanol in the mixed solution in the step (1) by a rotary evaporator, gradually overlapping the unfolded alkaline dissociation proteins, starting to converge the loose structure, allowing lutein to undergo first embedding, returning the aggregated alkaline protein particles to a state of being separated from each other when no ethanol is added, reducing the particle size, and clarifying the solution again. The rotary evaporation vacuum degree is 0.05MPa, the heating temperature is 40 ℃, and the rotating speed is 100rpm.
(3) And (3) regulating the pH value of the mixed solution obtained in the step (2) to 7.0 by using a 2M hydrochloric acid solution, rearranging subunits separated from each other by electrostatic repulsive force, carrying out protein second overlapping, carrying out secondary embedding on lutein, enabling a loose structure to become compact, adding water with the same volume as ethanol removed by evaporation, and enabling the final concentration of protein to be 10mg/mL, thus obtaining the protein-based lutein nanoparticle.
Method 2: the method for preparing the protein-based lutein nanoparticle by combining pH with ethanol to induce protein to assemble nano-embedded lutein is the same as the method 1 in the embodiment, and the difference is that the protein in the step (1) is sodium caseinate.
Method 3: the method for preparing protein-based lutein nanoparticle by combining pH and ethanol to induce protein assembly nano-embedded lutein is the same as the method 1 in the embodiment, and the difference is that the protein in the step (1) is soybean protein isolate.
Example 2
Method 1: the protein-based lutein nanoparticle prepared by a method for assembling nano-embedded lutein by utilizing pH and ethanol to induce protein comprises the following steps:
(1) The isolated soy protein was dispersed in water to an initial concentration of 16.7mg/mL, the pH of the dispersion was adjusted to 10.0 with 4M NaOH solution, and magnetic stirring was continued at 1000rpm/min for 120min at room temperature to allow the protein to be fully unfolded or dissociated and the solution became clear and transparent. 1.5mg/mL of lutein-absolute ethanol solution is dripped into the alkaline dissociating protein dispersion liquid to ensure that the absolute ethanol concentration reaches 40% (v/v) of the mixed liquid, the pH value is maintained at 10.0 during the period, the final concentration of the alkaline dissociating protein is 10.0mg/mL, and the magnetic stirring is continued at the speed of 1000rpm/min for 60min at room temperature. Under the action of ethanol, the alkaline dissociative protein is further unfolded to fully expose hydrophobic groups, on one hand, the alkaline dissociative protein forms a complex with lutein through hydrophobic interaction, on the other hand, the alkaline dissociative protein is aggregated into loose large particles, and the solution becomes turbid.
(2) Removing the ethanol in the mixed solution in the step (1) by a rotary evaporator, gradually overlapping the unfolded alkaline dissociation proteins, starting to converge the loose structure, allowing lutein to undergo first embedding, returning the aggregated alkaline protein particles to a state of being separated from each other when no ethanol is added, reducing the particle size, and clarifying the solution again. The rotary evaporation vacuum degree is 0.05MPa, the heating temperature is 40 ℃, and the rotating speed is 100rpm.
(3) And (3) regulating the pH value of the mixed solution obtained in the step (2) to 7.0 by using a 2M hydrochloric acid solution, rearranging subunits separated from each other by electrostatic repulsive force, carrying out protein second overlapping, carrying out secondary embedding on lutein, enabling a loose structure to become compact, adding water with the same volume as ethanol removed by evaporation, and enabling the final concentration of protein to be 10.0mg/mL, thus obtaining the protein-based lutein nanoparticle.
Method 2: the preparation method of the protein-based lutein nanoparticle prepared by combining pH with ethanol to induce protein assembly nano-embedded lutein is the same as the method 1 in the embodiment, and the difference is that the pH in the step (1) is 11.0.
Method 3: the protein-based lutein nanoparticle prepared by a method for assembling nano-embedded lutein by utilizing pH and ethanol to induce protein is different from the method 1 in the embodiment only in that the pH in the step (1) is 12.0.
Example 3
Method 1: the protein-based lutein nanoparticle prepared by a method for assembling nano-embedded lutein by utilizing pH and ethanol to induce protein comprises the following steps:
(1) The isolated soy protein was dispersed in water to an initial concentration of 8.3mg/mL, the pH of the dispersion was adjusted to 11.0 with 4M NaOH solution, and magnetic stirring was continued at 1000rpm/min for 120min at room temperature to allow the protein to be fully unfolded or dissociated and the solution became clear and transparent. 1.5mg/mL of lutein-absolute ethanol solution is dripped into the alkaline dissociating protein dispersion liquid to ensure that the absolute ethanol concentration reaches 40% (v/v) of the mixed liquid, the pH value is maintained at 11.0 during the period, the final concentration of the alkaline dissociating protein is 5.0mg/mL, and the magnetic stirring is continued at the speed of 1000rpm/min for 90min at room temperature. Under the action of ethanol, the alkaline dissociative protein is further unfolded to fully expose hydrophobic groups, on one hand, the alkaline dissociative protein forms a complex with lutein through hydrophobic interaction, on the other hand, the alkaline dissociative protein is aggregated into loose large particles, and the solution becomes turbid.
(2) Removing the ethanol in the mixed solution in the step (1) by a rotary evaporator, gradually overlapping the unfolded alkaline dissociation proteins, starting to converge the loose structure, allowing lutein to undergo first embedding, returning the aggregated alkaline protein particles to a state of being separated from each other when no ethanol is added, reducing the particle size, and clarifying the solution again. The rotary evaporation vacuum degree is 0.05MPa, the heating temperature is 40 ℃, and the rotating speed is 100rpm.
(3) And (3) regulating the pH value of the mixed solution obtained in the step (2) to 7.0 by using a 2M hydrochloric acid solution, rearranging subunits separated from each other by electrostatic repulsive force, carrying out protein second overlapping, carrying out secondary embedding on lutein, enabling a loose structure to become compact, adding water with the same volume as ethanol removed by evaporation, and enabling the final concentration of protein to be 5.0mg/mL, thus obtaining the protein-based lutein nanoparticle.
Method 2: the protein-based lutein nanoparticle prepared by the method for assembling nano-embedded lutein by utilizing pH and ethanol to induce protein is the same as the method 1 in the embodiment, and the difference is that the initial protein concentration in the step (1) is 20.8mg/mL, and the final protein concentration in the step (1) and the step (3) is 12.5mg/mL.
Method 3: the protein-based lutein nanoparticle prepared by the method for assembling nano-embedded lutein by utilizing pH and ethanol to induce protein is the same as the method 1 in the embodiment, and the difference is that the initial protein concentration in the step (1) is 33.3mg/mL, and the final protein concentration in the step (1) and the step (3) is 20.0mg/mL.
Method 4: the protein-based lutein nanoparticle prepared by the method for assembling nano-embedded lutein by utilizing pH and ethanol to induce protein is the same as the method 1 in the embodiment, and the difference is that the initial protein concentration in the step (1) is 41.7mg/mL, and the final protein concentration in the step (1) and the step (3) is 25.0mg/mL.
Example 4
Method 1: the protein-based lutein nanoparticle prepared by a method for assembling nano-embedded lutein by utilizing pH and ethanol to induce protein comprises the following steps:
(1) The isolated soy protein was dispersed in water to an initial concentration of 16.7mg/mL, the pH of the dispersion was adjusted to 12.0 with 4M NaOH solution, and magnetic stirring was continued at 1000rpm/min for 120min at room temperature to allow the protein to be fully unfolded or dissociated and the solution became clear and transparent. 1.5mg/mL of lutein-absolute ethyl alcohol solution is dripped into the alkaline dissociating protein dispersion liquid to ensure that the absolute ethyl alcohol concentration reaches 40% (v/v) of the mixed liquid, the pH value is maintained at 12.0 during the period, the final concentration of the alkaline dissociating protein is 10.0mg/mL, and the magnetic stirring is continuously carried out at the speed of 1000rpm/min for 120min at room temperature. Under the action of ethanol, the alkaline dissociative protein is further unfolded to fully expose hydrophobic groups, on one hand, the alkaline dissociative protein forms a complex with lutein through hydrophobic interaction, on the other hand, the alkaline dissociative protein is aggregated into loose large particles, and the solution becomes turbid.
(2) Removing the ethanol in the mixed solution in the step (1) by a rotary evaporator, gradually overlapping the unfolded alkaline dissociation proteins, starting to converge the loose structure, allowing lutein to undergo first embedding, returning the aggregated alkaline protein particles to a state of being separated from each other when no ethanol is added, reducing the particle size, and clarifying the solution again. The rotary evaporation vacuum degree is 0.05MPa, the heating temperature is 40 ℃, and the rotating speed is 100rpm.
(3) And (3) regulating the pH value of the mixed solution obtained in the step (2) to 7.0 by using a 2M hydrochloric acid solution, rearranging subunits separated from each other by electrostatic repulsive force, carrying out protein second overlapping, carrying out secondary embedding on lutein, enabling a loose structure to become compact, adding water with the same volume as ethanol removed by evaporation, and enabling the final concentration of protein to be 10.0mg/mL, thus obtaining the protein-based lutein nanoparticle.
Method 2: the preparation method of the protein-based lutein nanoparticle prepared by the method of combining pH with ethanol to induce protein to assemble nano-embedded lutein is the same as the method 1 in the embodiment, and the difference is that the ethanol concentration in the step (1) is 50% (v/v) of the mixed solution.
Method 3: the preparation method of the protein-based lutein nanoparticle prepared by the method of combining pH with ethanol to induce protein to assemble nano-embedded lutein is the same as the method 1 in the embodiment, and the difference is that the ethanol concentration in the step (1) is 60% (v/v) of the mixed solution.
Comparative example 1
Method 1: a protein-based lutein nanoparticle prepared by ethanol induction comprises the following steps:
(1) The isolated soy protein was dispersed in water to an initial concentration of 16.7mg/mL, adjusted to pH 7.0 with 4M NaOH solution and magnetically stirred at 1000rpm/min for 120min at room temperature. 1.5mg/mL lutein-absolute ethanol solution is dripped into the protein dispersion liquid to ensure that the ethanol concentration reaches 40% (v/v) of the mixed liquid, the final concentration of the protein is 10.0mg/mL, and the magnetic stirring is continuously carried out for 120min at the speed of 1000rpm/min at room temperature. Under the action of ethanol, the protein gradually unfolds to expose hydrophobic groups, forming a complex with lutein through hydrophobic interaction on the one hand, and aggregating into loose large particles on the other hand, so that the solution becomes turbid.
(2) Removing ethanol in the mixed solution in the step (1) by a rotary evaporator, gradually overlapping the unfolded protein to form a compact structure, and heating at 40 ℃ and rotating at 100rpm under the rotary evaporation vacuum degree of 0.05 MPa. The pH was adjusted to 7.0 with 2M hydrochloric acid solution, and water was added in the same volume as the ethanol removed by evaporation, so that the final concentration of isolated soy protein was 10mg/mL.
Method 2: the preparation method of the protein-based lutein nanoparticle prepared by ethanol induction is the same as that of the method 1 in the embodiment, and only the difference is that the ethanol concentration in the step (1) is 50% (v/v) of the mixed solution.
Method 3: the preparation method of the protein-based lutein nanoparticle prepared by ethanol induction is the same as that of the method 1 in the embodiment, and the difference is that the ethanol concentration in the step (1) is 60% (v/v) of the mixed solution.
Effect examples
1. Particle size, PDI and lyophilization yield of the protein-based lutein nanoparticles obtained in example 1
The protein-based lutein nanoparticle prepared from whey protein isolate, sodium caseinate and soy protein isolate in example 1 was diluted to a protein concentration of 1mg/mL, the experiment was repeated three times, and the hydrated particle size and PDI (Polymer dispersity index, polymer dispersibility index, used to describe the polymer molecular weight distribution) were measured using a malvern nanoparticle size and potential analyzer, and the results are shown in table 1 and fig. 2.
In the appearance diagram in fig. 1 (a), the turbidity of the solution prepared by whey protein isolate is highest, and in fig. 2, the particle size of the whey protein isolate lutein nanoparticle is in obvious bimodal distribution, which indicates that more association and aggregation of protein exist, on one hand, because ethanol with a certain concentration has the effect of promoting aggregation of protein molecules; on the other hand, whey protein isolate is relatively weak in the ability to bind lutein through hydrophobic interactions due to lack of sufficient hydrophobic sites in the structure, strong surface hydrophilicity, weak amphipathic subunits, etc., and the proteins are more easily bound to each other, so that larger particles are easily formed. The soy protein isolate and the sodium caseinate are more easily combined with lutein because of having good amphipathic property and more hydrophobic sites, the lutein is encapsulated in the recombinant protein, the average particle size of the recombinant particles is smaller, and the solution prepared from the soy protein isolate and the sodium caseinate in the figure 1 (a) has the characteristics of clarity and transparency. Although the particle size of the soy protein isolate based lutein nanoparticles is slightly larger than the particles prepared from sodium caseinate, the polydispersity index is minimal and the soy protein isolate is more widely available and readily available than sodium caseinate and is therefore widely used in the examples of this patent.
The protein-based lutein nanoparticle solution prepared from the different proteins in example 1 was freeze-dried to give pale yellow powder as shown in fig. 3. In all the dried powders, no crystalline particles of lutein were found, which fully suggests that lutein in the protein-based lutein nanoparticles is efficiently entrapped and that lutein is relatively stable in protein binding.
The freeze-drying yield is calculated according to the formula (1), wherein W 2 To the mass of the granules obtained after drying, W 1 The results are shown in Table 1 for the mass of the non-evaporable particles contained in the formulation (i.e., protein and lutein). The protein-based lutein nano particles have higher yield after vacuum freeze drying, and the yield is more than 80 percent.
TABLE 1 average particle size, PDI, and lyophilization yield of nanoparticles prepared in example 1
2. Particle size, PDI, encapsulation efficiency and loading of the protein-based lutein nanoparticle obtained in example 2
The appearance of the protein-based lutein nanoparticle in the form of solution obtained in example 2 is shown in fig. 1 (b), and the solution is clear and transparent. The hydrated particle size and PDI of the protein-based lutein nanoparticles prepared under different pH conditions in example 2 are shown in table 2, and in alkaline state, the average particle size of the obtained nanoparticles gradually decreases with increasing pH, the average particle size of the prepared nanoparticles is maximum at ph=10, and is 157.5±9.0nm, and when pH is 11-12, the average particle sizes of the particles are relatively close, 134.2±5.4nm and 127.1±5.7nm, respectively. This is because the greater the pH in alkaline condition, the higher the extent of protein unfolding and dissociation, the more sites available for hydrophobic binding to lutein, and the smaller and denser the recombinant particle structure formed. As can also be seen from fig. 4, the larger the pH in the alkaline state, the larger the area ratio of the small particle diameter peak, and the whole particle diameter distribution map moves in the direction of smaller particle diameter.
The encapsulation efficiency and the load of the protein-based lutein nanoparticle in the form of solution obtained in example 2 were measured, the experiment was repeated three times, and the calculation was performed according to formulas (2) and (3), and the results are shown in table 2, in which the encapsulation efficiency has a significant negative correlation with the particle size. In an alkaline state, as the pH is increased, the more the protein is unfolded and dissociated, the more sites can be subjected to hydrophobic binding with lutein; after the pH is adjusted back to 7, the more lutein is encapsulated in the protein, the higher the encapsulation efficiency is, and the load capacity is increased under the condition of the same protein concentration.
Table 2 average particle diameter, PDI, encapsulation efficiency and load of nanoparticles prepared in example 2
3. Particle size, PDI, heat treatment stability and light treatment stability of the protein-based lutein nanoparticle obtained in example 3
The appearance of the protein-based lutein nanoparticle in the form of solution prepared in example 3 is shown in fig. 1 (c), and the turbidity of the solution increases with the increase of the protein concentration. The hydrated particle size and PDI of the protein-based lutein nanoparticles prepared in example 3 at different protein concentrations are shown in Table 3 and FIG. 5. With the increase of the protein concentration, the average particle size and PDI of the protein-based lutein nanoparticle prepared by the method of combining pH with ethanol to induce protein to assemble nano-embedded lutein are firstly reduced and then increased, and when the protein concentration is 12.5mg/mL, the average particle size and PDI are minimum, namely 129.2+/-1.8 nm and 0.351+/-0.004 nm respectively; when the protein concentration is as high as 25.0mg/mL, although the particle size of particles formed by protein unfolding or dissociation is obviously reduced under the condition of pH=12, the protein concentration is increased from 25.0mg/mL to 41.7mg/mL after ethanol is removed, the probability of collision among protein molecules is increased in the process of adjusting the pH to 7, large particles are more easily formed, even if distilled water is supplemented to restore the protein concentration to 25.0mg/mL, the size of the self-assembled nano particles cannot be changed, and the average particle size of the protein-based lutein nano particles prepared under the protein concentration is 235.7+/-2.4 nm; when the protein concentration is as low as 5.0mg/mL, the lutein content required to be loaded per unit protein is increased, so that the aggregation degree among proteins is increased, and the average particle size of the formed nano particles is correspondingly increased and is 151.8+/-3.6 nm.
TABLE 3 average particle diameter and PDI of nanoparticles prepared in example 3
7mL of the protein-based lutein nanoparticle solution prepared in the embodiment 3 and 7mL of the 1mg/mL lutein-absolute ethyl alcohol solution are respectively taken and placed in a water bath kettle at 80 ℃ for 4 hours for heat treatment, the lutein content is measured at 0h, 0.5h, 1h, 2h and 4h, the experiment is repeated three times, and the lutein retention rate is calculated according to the formula (4), and the result is shown in figure 6. After heat treatment for 4 hours at 80 ℃, the retention rate of lutein in the protein-based lutein nano-particles provided by the embodiment is over 80 percent, and the retention rate of free lutein is only 9.97+/-0.43% under the same condition, which indicates that the protein-based lutein nano-particles provided by the embodiment can obviously improve the thermal stability of lutein.
7mL of the protein-based lutein nanoparticle solution prepared in the embodiment 3 with different protein concentrations and 7mL of 1mg/mL of lutein-absolute ethanol solution are respectively taken and irradiated under 254nm and 365nm ultraviolet light, the lutein content is measured in 0h, 2h, 4h, 8h and 24h, the experiment is repeated three times, and the lutein retention rate is calculated according to the formula (4), and the result is shown in figure 7. After 24h ultraviolet irradiation, the retention rate of lutein in the protein-based lutein nano-particles provided by the embodiment is over 70 percent, and the retention rate of free lutein is only 1.58 percent under the same condition, which indicates that the protein-based lutein nano-particles provided by the embodiment can obviously improve the illumination stability of lutein.
4. Particle size, PDI, long-term storage stability, in vitro digestion stability and bioavailability of the protein-based lutein nanoparticles obtained in example 4
The hydrated particle size and PDI of the protein-based lutein nanoparticles prepared by different ethanol concentrations in example 4 and comparative example 1 are shown in Table 4 and FIG. 8, and the average particle size of the protein-based lutein nanoparticles prepared by the method for assembling nano-embedded lutein by pH-synergistic ethanol-induced protein under the same ethanol concentration condition is smaller than that of the nanoparticles prepared by ethanol-induced alone.
The average particle size (123.3+ -1.9 nm) of the protein-based lutein nanoparticle prepared in example 4 was smaller than that of comparative example 1 (167.8+ -2.4 nm) under the condition of 40% ethanol concentration; the same rule is also adopted when the concentration of ethanol is 50%, namely, the average particle size (162.7+/-4.8 nm) of the protein-based lutein nano-particles prepared in the example 4 is smaller than that of the comparative example 1 (382.0 +/-21.3 nm); when the ethanol concentration was increased to 60%, the nanoparticle size (269.3.+ -. 0.9 nm) prepared in example 4 was still smaller than that of comparative example 1 (405.3.+ -. 16.8 nm).
As can be seen from fig. 8, compared with the nanoparticles prepared by ethanol induction alone, the particle size distribution diagram of the nanoparticles prepared by the method for assembling nano-embedded lutein by using the pH-collaborative ethanol-induced protein moves toward a smaller particle size, and when the ethanol concentration is 40% and 50%, the particle size of the nanoparticles shows a unimodal distribution, which is consistent with smaller PDI, indicating that the method for assembling nano-embedded lutein by using the pH-collaborative ethanol-induced protein can obtain protein-based lutein nanoparticles with smaller particle size and more uniform distribution. This is probably because under ph=12 conditions, the protein is sufficiently unfolded and even dissociated into smaller size subunits under alkaline conditions than induced by ethanol alone, and although the protein forms loose, larger aggregates in the presence of ethanol, the aggregates return to a state of separation from each other when ethanol is not added after rotary evaporation to remove ethanol, and the particle size is significantly smaller; the cells in which self-assembly occurs are smaller in size so that the resulting particles are also smaller and more uniform.
As can be seen from table 4 and fig. 8, as the ethanol concentration gradually increases, the particle size of the prepared nanoparticles also gradually increases. This is because ethanol has an effect of promoting aggregation of proteins, and the higher the concentration of ethanol, the more remarkable the aggregation of proteins, and as can be seen from (d) of FIG. 1, the solution becomes clear and transparent when the concentration of ethanol is 40% -50%, and becomes cloudy when the concentration of ethanol is increased to 60%.
TEM observation was performed on the protein-based lutein nanoparticles prepared under the condition of 40% ethanol concentration in example 4 and comparative example 1, and as shown in FIG. 9, the microscopic morphology of the nanoparticles provided in example 4 is in a regular circle, and the size is smaller and the distribution is more uniform than that of comparative example 1.
As can be seen from table 4, the protein-based lutein nanoparticle prepared by the method for assembling nano-embedded lutein by using the pH-synergistic ethanol-induced protein shows higher encapsulation efficiency and loading capacity, and the encapsulation efficiency of example 1 is higher than 90% and higher than that of comparative example 1. The method is characterized in that the protein is subjected to secondary unfolding and secondary folding in the preparation method of the protein assembled nano-embedded lutein by the pH synergistic ethanol induction, when the protein is in a pH=12 condition, the protein molecules are greatly unfolded or even dissociated Cheng Yaji, and the exposure degree of the hydrophobic groups is increased; when the lutein-absolute ethyl alcohol solution is introduced into the system, the protein structure is further unfolded by the ethyl alcohol, lutein and fully unfolded alkaline protein are quickly combined through hydrophobic interaction, lutein is encapsulated in a hydrophobic cavity of the alkaline protein for the first time in the process of removing the folding of the ethyl alcohol protein, the protein is folded and recombined again in the process of adjusting the pH value, the loose structure becomes compact, and the lutein originally positioned on the surface of the protein is encapsulated inside, so that the encapsulation rate is improved. When the ethanol concentration and the protein concentration are consistent, the higher the encapsulation efficiency is, the higher the load is.
Table 4 average particle diameter, PDI, encapsulation efficiency and load of nanoparticles prepared in example 4 and comparative example 1
5mL of the solution of the protein-based lutein nanoparticle prepared in the example 4 and 5mL of the free lutein-absolute ethyl alcohol solution are taken respectively, the solution is stored for 45 days in a dark place at 35 ℃ in an incubator, the lutein content is measured at 0d,7d,15d and 45d, the experiment is repeated three times, and the long-time storage retention rate of lutein is calculated according to the formula (4). As can be seen from FIG. 10, the retention rate of free lutein after being stored at 35 ℃ for 7d is only 4.60+/-0.16%, and the retention rate of lutein in the nano-particles provided in example 4 is above 90%, and the retention rate of lutein after 45d is also above 70%, which indicates that the protein-based lutein nano-particles provided in the example can remarkably improve the long-term storage stability of lutein.
A simulated in vitro digestion experiment was performed on 5mL of the protein-based lutein nanoparticle solution prepared in example 4 and 5mL of 1mg/mL lutein-absolute ethanol solution to determine the digestion stability and bioavailability thereof, and the experiment was repeated three times, and the results are shown in FIG. 11 and FIG. 12. After 120 minutes of simulated gastric digestion, the average retention of lutein in the form of solution (40%, 50%, 60%) was 97%, 94%, 93%, respectively, while the retention of free lutein was 88%; after digestion for 120 min in simulated small intestine, the retention of lutein in the protein-based lutein nanoparticles in solution form is above 85%, while the retention of free lutein is reduced to 35%. After the whole digestion process is finished, the average value of lutein bioavailability (the content of lutein in the supernatant after 10000g of digestion solution is centrifuged for 30min reflects the bioavailability) of the protein-based lutein nano particles (40% ethanol concentration, 50% ethanol concentration and 60% ethanol concentration) in the form of the solution prepared in the embodiment 4 is 38%, 32% and 30%, and the bioavailability of free lutein is only 4%. The protein-based lutein nanoparticle provided in the embodiment 4 can obviously improve the digestion stability and bioavailability of lutein, can be used as a raw material or an auxiliary material to be added into medicines and foods, and has great market potential.
Claims (10)
1. The method for assembling the nano-embedded lutein by utilizing the pH and ethanol to induce the protein is characterized by comprising the following steps of:
(1) The pH of the protein dispersion is adjusted to be in an alkaline state, and the protein is fully stirred to be unfolded or dissociated into subunits, so that the particle size is obviously reduced, and the solution becomes clear and transparent; then adding a lutein-absolute ethyl alcohol solution, enabling the alkaline dissociated protein to be further unfolded through alcohol-water interaction, fully stirring to enable lutein to form a stable compound with the protein through hydrophobic interaction, and meanwhile, enhancing the hydrophobic interaction among alkaline dissociated protein particles to form a loose aggregate with larger size, so that the solution becomes turbid;
(2) Removing ethanol in the mixed solution by rotary evaporation, gradually overlapping the unfolded alkaline dissociation proteins, starting to converge the loose structure, enabling lutein to undergo first embedding, enabling the aggregated alkaline protein particles to return to a state of being separated from each other when no ethanol is added, remarkably reducing the particle size, and clarifying the solution again;
(3) Regulating pH of the mixed solution to be neutral, carrying out rearrangement of subunits separated from each other originally by electrostatic repulsive force, carrying out secondary overlapping and recombination on protein, carrying out secondary embedding on lutein, enabling a loose structure to become compact, and adding water with the same volume as ethanol removed by evaporation to obtain the protein-based lutein nano-particles.
2. The method for assembling nano-embedded lutein by utilizing pH-coordinated ethanol-induced protein according to claim 1, wherein in the step (1), the protein is at least one of whey protein, serum protein, ovalbumin, lysozyme, beta-lactoglobulin, sodium caseinate, legume 7S globulin, legume 11S globulin, soy protein isolate and pea protein isolate.
3. The method for assembling nano-embedded lutein by utilizing pH to cooperate with ethanol to induce protein according to claim 1, wherein in the step (1), the protein concentration is 1-60mg/mL.
4. The method for assembling nano-embedded lutein by utilizing pH to cooperate with ethanol to induce protein according to claim 1, wherein in the step (1), the pH of the protein dispersion liquid is in the range of 10-12.
5. The method for assembling nano-embedded lutein by utilizing pH to cooperate with ethanol to induce protein according to claim 1, wherein in the step (1), the protein is fully stirred to be unfolded or dissociated into subunits, and the stirring time is 30-120min.
6. The method for assembling nano-embedded lutein by utilizing pH synergistic alcohol induced protein according to claim 1, wherein in the step (1), the volume ratio of the added lutein-absolute alcohol solution is 10% -70% of the mixed solution, and the stirring time is 30-120min.
7. The method for assembling nano-embedded lutein by utilizing pH to cooperate with ethanol to induce protein according to claim 1, wherein in the step (2), the rotary evaporation vacuum degree is 0-0.1MPa, the heating temperature is 35-45 ℃, and the rotating speed is 80-120rpm.
8. The method for assembling nano-embedded lutein by utilizing pH to cooperate with ethanol induced protein according to claim 1, wherein in the step (3), the pH is adjusted to be 6.8-8.0.
9. The protein-based lutein nanoparticle prepared by the preparation method of any one of claims 1 to 8.
10. The use of the protein-based lutein nanoparticle of claim 9: pigments, foods, medicines or feeds.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310243522.3A CN116391864A (en) | 2023-03-14 | 2023-03-14 | Method for assembling nano-embedded lutein by pH (potential of hydrogen) synergistic ethanol-induced protein, protein-based lutein nanoparticle and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310243522.3A CN116391864A (en) | 2023-03-14 | 2023-03-14 | Method for assembling nano-embedded lutein by pH (potential of hydrogen) synergistic ethanol-induced protein, protein-based lutein nanoparticle and application |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116391864A true CN116391864A (en) | 2023-07-07 |
Family
ID=87013312
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310243522.3A Pending CN116391864A (en) | 2023-03-14 | 2023-03-14 | Method for assembling nano-embedded lutein by pH (potential of hydrogen) synergistic ethanol-induced protein, protein-based lutein nanoparticle and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116391864A (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090311329A1 (en) * | 2006-04-20 | 2009-12-17 | Technion Research And Development Foundation Ltd | Casein micelles for nanoencapsulation of hydrophobic compounds |
CN109511772A (en) * | 2018-11-26 | 2019-03-26 | 华南理工大学 | A kind of dissolution, synergy indissoluble bioactive substance albumen base nano particle preparation method |
CN109588721A (en) * | 2019-01-25 | 2019-04-09 | 集美大学 | One Carotenoids-protein particle and its preparation method and application |
CN113080452A (en) * | 2021-04-21 | 2021-07-09 | 华南理工大学 | High-load and high-stability protein-based curcumin product and preparation method and application thereof |
CN114403446A (en) * | 2022-01-28 | 2022-04-29 | 华南理工大学 | High-stability and high-concentration turmeric extract aqueous solution and preparation method and application thereof |
CN115590194A (en) * | 2022-10-27 | 2023-01-13 | 江南大学(Cn) | Preparation method of lutein-loaded soybean peptide with high loading capacity and high stability |
-
2023
- 2023-03-14 CN CN202310243522.3A patent/CN116391864A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090311329A1 (en) * | 2006-04-20 | 2009-12-17 | Technion Research And Development Foundation Ltd | Casein micelles for nanoencapsulation of hydrophobic compounds |
CN109511772A (en) * | 2018-11-26 | 2019-03-26 | 华南理工大学 | A kind of dissolution, synergy indissoluble bioactive substance albumen base nano particle preparation method |
CN109588721A (en) * | 2019-01-25 | 2019-04-09 | 集美大学 | One Carotenoids-protein particle and its preparation method and application |
CN113080452A (en) * | 2021-04-21 | 2021-07-09 | 华南理工大学 | High-load and high-stability protein-based curcumin product and preparation method and application thereof |
CN114403446A (en) * | 2022-01-28 | 2022-04-29 | 华南理工大学 | High-stability and high-concentration turmeric extract aqueous solution and preparation method and application thereof |
CN115590194A (en) * | 2022-10-27 | 2023-01-13 | 江南大学(Cn) | Preparation method of lutein-loaded soybean peptide with high loading capacity and high stability |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhang et al. | Nanostructures of protein-polysaccharide complexes or conjugates for encapsulation of bioactive compounds | |
Ding et al. | Fabrication and characterization of soybean oil bodies encapsulated in maltodextrin and chitosan-EGCG conjugates: An in vitro digestibility study | |
Yuan et al. | One-step self-assembly of curcumin-loaded zein/sophorolipid nanoparticles: physicochemical stability, redispersibility, solubility and bioaccessibility | |
Zhao et al. | Modification of functional properties of perilla protein isolate by high-intensity ultrasonic treatment and the stability of o/w emulsion | |
CN105410934B (en) | A kind of water-solubility protein-phytosterol nano particle and preparation and application | |
Wang et al. | Structural interplay between curcumin and soy protein to improve the water-solubility and stability of curcumin | |
CN108030088B (en) | Preparation method of protein-modified phytosterol liposome powder | |
Adsare et al. | Microencapsulation of curcumin using coconut milk whey and Gum Arabic | |
CN109511772B (en) | Preparation method of protein-based nanoparticles of dissolution-promoting and synergistic insoluble bioactive substances | |
CN108208834B (en) | Curcumin-loaded soybean protein-based nanoparticles and preparation method and application thereof | |
CN109588721B (en) | Carotenoid-protein particle and preparation method and application thereof | |
US20230276832A1 (en) | Ultrasonic preparation method of protein-derived peptide-polysaccharide nanoparticles loaded with bioactive components | |
CN112370465A (en) | Sargassum fusiforme polysaccharide functionalized nano-selenium and preparation method and application thereof | |
WO2021088983A1 (en) | 7,8-dihydroxyflavone composite nano-biomaterial with high bioavailability, preparation method, and application thereof | |
CN113080452A (en) | High-load and high-stability protein-based curcumin product and preparation method and application thereof | |
CN108157585B (en) | Resveratrol-loaded soybean protein-based nano-particles and preparation method and application thereof | |
Yu et al. | Preparation of novel self-assembled albumin nanoparticles from Camellia seed cake waste for lutein delivery | |
CN114403446B (en) | High-stability high-concentration turmeric extract aqueous solution and preparation method and application thereof | |
Xu et al. | Soy protein isolate-citrus pectin-gallic acid ternary composite high internal phase Pickering emulsion for delivery of β-carotene: Physicochemical, structural and digestive properties | |
Chen et al. | Food emulsifier based on the interaction of casein and butyrylated dextrin for improving stability and emulsifying properties | |
CN116391864A (en) | Method for assembling nano-embedded lutein by pH (potential of hydrogen) synergistic ethanol-induced protein, protein-based lutein nanoparticle and application | |
Shen et al. | Design of soy protein/peptide-based colloidal particles and their role in controlling the lipid digestion of emulsions | |
Du et al. | Preparation, characterization and functional properties of ternary composite nanoparticles for enhanced water solubility and bioaccessibility of lutein | |
CN115607524B (en) | Curcumin-loaded composite nanoparticle and preparation method thereof | |
AU2002356404B2 (en) | Carotenoid formulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |